Danish Medicines Agency

Theme

Think before you buy

See our new campaign about how to protect yourself when buying medicines – whether at the pharmacy, in retail stores, or online.

Go to theme

Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

Industry

Information on licensing, inspections, fees, company authorisations, clinical trials and more.

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.

Report a side effect from medicines About Brexit International activities Transparency Subscribe to news in English Mission, vision and strategy Whistleblower scheme New veterinary medicinal products regulation Reporting product defects Inspections Jobs 0

News

Register-based study suggests a slightly increased risk of meningiomas in women using hormonal contraception containing a progestogen

03 July 2026

A study of 25 years of data from Danish women aged 15-59 suggests that meningiomas (tumours of the meninges) may be a very rare side effect of contraceptives containing a progestogen. The Danish Medicines Agency is therefore raising a safety signal in the European Pharmacovigilance Risk Assessment Committee (PRAC).

Are you running clinical trials? You can now activate e-mail notifications in CTIS

29 June 2026

Are you working with cell therapy and planning a clinical trial?

25 June 2026

The guidance on digital and decentralised clinical trials (DCT) has been updated

09 June 2026